O
Oaktree Acquisition Corp. III Life Sciences
OACCUCIK 0002029769NasdaqNon-AcceleratedSmaller ReportingEmerging GrowthBlank ChecksE9FY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
$7.29M
Total Assets
$203.11M
Equity
$-6.77M
Shares Out
—
Op. Cash Flow
$-422.1K
Business
Oaktree Acquisition Corp. III Life Sciences is a special purpose acquisition company that seeks to effect an initial business combination in the life sciences sector. It offers public units, Class A ordinary shares and warrants and maintains a trust account to hold IPO proceeds while sourcing targets and negotiating transactions. Its principal functional groups include the sponsor/founders, public shareholders and underwriters, which influence voting, redemption and financing dynamics. The company accesses U.S. public capital markets and private negotiated transactions and may pursue targets globally.
Summary from filing dated 2025-03-27
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 |
|---|---|---|
| General and administrative expenses | 1 | |
| Loss from operations | −1 | |
| Change in fair value of over-allotment liability | 0 | |
| Interest earned on cash held in Trust Account | 8 | |
| Total other income | 8 | |
| Net income | 7 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2024 2024-06-30 |
|---|---|---|---|---|
| Cash | 1 | 1 | — | |
| Prepaid expenses | 113,275 | 201,281 | — | |
| Total current assets | 2 | 2 | — | |
| Long-term prepaid insurance | 0 | 113,275 | — | |
| Cash held in Trust Account | 202 | 194 | — | |
| TOTAL ASSETS | 203 | 195 | — | |
| Accounts payable and accrued expenses | 501,968 | 535,515 | — | |
| Accrued offering costs | 0 | 179,984 | — | |
| Due to related party | 785,857 | 0 | — | |
| Promissory note - related party | 11,824 | 11,824 | — | |
| Total current liabilities | 1 | 727,323 | — | |
| Deferred legal fees | 299,088 | 299,088 | — | |
| Deferred underwriting fee payable | 7 | 7 | — | |
| Total Liabilities | 8 | 8 | — | |
| Commitments and Contingencies (Note 5) | — | — | — | |
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 19,199,029 issued and outstanding as of December 31, 2025 and 2024; at redemption value of $10.50 and $10.08 per share as of December 31, 2025 and 2024, respectively | 202 | 194 | — | |
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024 | 0 | 0 | — | |
| Additional paid-in capital | 0 | 0 | — | |
| Accumulated deficit | −7 | −6 | — | |
| Total Shareholders' Deficit | −7 | −6 | 0 | |
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT | 203 | 195 | — |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 |
|---|---|---|
| Payment of operating costs through promissory note | 0 | |
| Prepaid expenses | 88,005 | |
| Long Term prepaid insurance | 113,275 | |
| Accounts payable and accrued expenses | −33,545 | |
| Accrued offering costs | −179,984 | |
| Due to related party | 785,857 | |
| Net cash used in operating activities | −422,079 | |
| Investment of cash in Trust Account | 0 | |
| Cash withdrawn from Trust Account for allowable working capital purposes | 500,000 | |
| Net cash provided by investing activities | 500,000 | |
| Proceeds from sale of Units, net of underwriting discounts paid | 0 | |
| Proceeds from sale of Private Placement Units | 0 | |
| Repayment of promissory noterelated party | 0 | |
| Net cash provided by financing activities | 0 | |
| Net Change in Cash | 77,921 | |
| Offering costs included in accrued offering costs | 0 | |
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | 0 | |
| Deferred offering costs paid through promissory noterelated party | 0 | |
| Prepaid services contributed by Sponsor through promissory noterelated party | 0 | |
| Deferred underwriting fee payable | 0 | |
| Deferred legal fee payable | 0 | |
| Forfeiture of Founder Shares | 0 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro